Insider Selling: Maximus, Inc. (NYSE:MMS) Insider Sells $988,030.00 in Stock

Maximus, Inc. (NYSE:MMS) insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Maximus Trading Down 1.2 %

MMS opened at $65.95 on Friday. The firm has a market cap of $3.73 billion, a P/E ratio of 14.18 and a beta of 0.72. The business has a fifty day simple moving average of $73.79 and a 200-day simple moving average of $81.67. Maximus, Inc. has a 52 week low of $64.53 and a 52 week high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last released its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.82%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Maximus by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock valued at $488,829,000 after purchasing an additional 205,564 shares during the period. Mackenzie Financial Corp boosted its holdings in Maximus by 2.0% in the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider’s stock valued at $207,687,000 after purchasing an additional 55,583 shares during the period. Geode Capital Management LLC raised its stake in Maximus by 1.4% in the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider’s stock valued at $142,109,000 after buying an additional 21,532 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock valued at $105,001,000 after buying an additional 177,075 shares in the last quarter. Finally, Van Berkom & Associates Inc. raised its stake in Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after buying an additional 98,264 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MMS has been the subject of several research analyst reports. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.